Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3276
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05880849 | Choline Effects - Pre-symptomatic AD | ||
| NCT02882321 | Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT00004154 | Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer | ||
| NCT04296305 | Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain | ||
| NCT05092451 | Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances | ||
| NCT06635434 | An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients | ||
| NCT05714033 | A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial) | ||
| NCT00427765 | Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma | ||
| NCT03044600 | Gene Expression in Hyperparathyroidism | ||
| NCT05495464 | A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma | ||
| NCT02210104 | Adoptive Therapy Using Antigen-Specific CD4 T-Cells | ||
| NCT02663583 | Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell | ||
| NCT00431054 | Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer | ||
| NCT02910700 | Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma | ||
| NCT06412198 | A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations | ||
| NCT07298083 | DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins | ||
| NCT03634241 | Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study | ||
| NCT03318900 | T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer | ||
| NCT06049134 | Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy | ||
| NCT05046782 | Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology | ||
| NCT01143779 | FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib | ||
| NCT04875286 | Patient Reported Symptom Control With THC or CBD Use | ||
| NCT00903591 | Study of Radiation Exposure and Bilateral Breast Cancer | ||
| NCT00967369 | Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. | ||
| NCT02126553 | Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission | ||
| NCT00525980 | Cancer Genetics CD-ROM for Hispanics | ||
| NCT01200342 | Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma | ||
| NCT04062266 | AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission | ||
| NCT00506922 | Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT | ||
| NCT07045103 | A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study | ||
| NCT06769490 | Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia | ||
| NCT02380027 | PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not? | ||
| NCT00539227 | A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy | ||
| NCT00968461 | Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders | ||
| NCT05327270 | Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions | ||
| NCT01054313 | Docetaxel and Sirolimus in Patients With Advanced Malignancies | ||
| NCT01094860 | Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies | ||
| NCT03025256 | Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease | ||
| NCT01591356 | EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors | ||
| NCT04987281 | Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study | ||
| NCT00561444 | Quality of Life Study for Prostate Cancer Patients | ||
| NCT01538472 | Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma | ||
| NCT00487357 | MATCh Parents' Supplemental Survey | ||
| NCT00877500 | Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy | ||
| NCT02613728 | Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI) | ||
| NCT00824811 | Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel | ||
| NCT07565467 | ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes) | ||
| NCT00048100 | Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes | ||
| NCT00909207 | Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing | ||
| NCT00429507 | Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases |
